Загрузка страницы

CNBC's Meg Tirrell explains how the coronavirus vaccine data monitoring process works

U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. CNBC's Meg Tirrell reports the latest on the news. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC

https://www.cnbc.com/select/best-credit-cards/

#CNBC
#CNBCTV

Видео CNBC's Meg Tirrell explains how the coronavirus vaccine data monitoring process works канала CNBC Television
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
9 ноября 2020 г. 20:38:12
00:02:21
Другие видео канала
Pfizer board member Scott Gottlieb: States will manage distribution of coronavirus vaccinePfizer board member Scott Gottlieb: States will manage distribution of coronavirus vaccineThere's a lot to buy out there: Legendary investor Bill MillerThere's a lot to buy out there: Legendary investor Bill MillerWhy dividend-paying stocks are poised for a comebackWhy dividend-paying stocks are poised for a comebackPfizer board member Scott Gottlieb: '2021 will look very different from 2020'Pfizer board member Scott Gottlieb: '2021 will look very different from 2020'Here's how the distribution infrastructure will deploy Covid-19 vaccineHere's how the distribution infrastructure will deploy Covid-19 vaccineJim Cramer on Goldman Sachs's call that S&P will rally on vaccine newsJim Cramer on Goldman Sachs's call that S&P will rally on vaccine newsCovid-19 vaccine news and the ETF market: Analysts assess the impactCovid-19 vaccine news and the ETF market: Analysts assess the impactPfizer Says Early Data Shows Its Covid-19 Vaccine Is 90% Effective | MTP Daily | MSNBCPfizer Says Early Data Shows Its Covid-19 Vaccine Is 90% Effective | MTP Daily | MSNBCPfizer's COVID-19 vaccine is promising, but many questions remain | ABC NewsPfizer's COVID-19 vaccine is promising, but many questions remain | ABC NewsHow Will the EU Vaccinate 446 Million People? Europe's COVID Vaccination Plans Explained - TLDR NewsHow Will the EU Vaccinate 446 Million People? Europe's COVID Vaccination Plans Explained - TLDR NewsPfizer COVID Vaccine: A Doctor ExplainsPfizer COVID Vaccine: A Doctor ExplainsPfizer CEO says Covid-19 vaccine news is a ‘game changer’Pfizer CEO says Covid-19 vaccine news is a ‘game changer’COVID-19: What Pfizer’s vaccine trial means for the pandemicCOVID-19: What Pfizer’s vaccine trial means for the pandemicDoctor discusses Pfizer's COVID-19 vaccineDoctor discusses Pfizer's COVID-19 vaccinePfizer Says Early Data Shows Covid-19 Vaccine 90 Percent Effective | NBC Nightly NewsPfizer Says Early Data Shows Covid-19 Vaccine 90 Percent Effective | NBC Nightly NewsPfizer announces late-stage trials showed its vaccine likely effective | WNTPfizer announces late-stage trials showed its vaccine likely effective | WNTCovid-19 Vaccine 90 Percent Effective In First Analysis, Pfizer Says | Morning Joe | MSNBCCovid-19 Vaccine 90 Percent Effective In First Analysis, Pfizer Says | Morning Joe | MSNBCThere Are Many Unanswered Questions About Pfizer's Vaccine | The 11th Hour | MSNBCThere Are Many Unanswered Questions About Pfizer's Vaccine | The 11th Hour | MSNBCDr. William: Virus Is ‘Very Serious’ Despite Successful Pfizer Vaccine Trial | Stephanie RuhleDr. William: Virus Is ‘Very Serious’ Despite Successful Pfizer Vaccine Trial | Stephanie RuhlePfizer CEO sold $5.6 million stock in pre-planned sale on day of vaccine news releasePfizer CEO sold $5.6 million stock in pre-planned sale on day of vaccine news release
Яндекс.Метрика